Antineoplastic drugs in healthcare settings: Occupational exposure and risk graduation

Antineoplastic drugs (ADs) are hazardous medicinal products highlighted in the EU strategic framework on health and safety at work 2021–2027. To minimize workers' chronic exposure in oncologic settings, regular monitoring programs for these drugs are crucial and mandatory in the EU (Directive 2...

Full description

Bibliographic Details
Main Authors: Maria Francisca Portilha-Cunha, Pedro Norton, Arminda Alves, Ana R.L. Ribeiro, Adrián M.T. Silva, Mónica S.F. Santos
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2025-01-01
Series:Emerging Contaminants
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405665024001197